Provider 1316909203
NPI: 1316909203Share
Active Billing Period:2018-01→2024-06(78 months)
Extreme procedure concentration — 100% of $10.3M billed through a single code
Total Paid
$10.3M
$10,270,787
Total Claims
2,548
Beneficiaries
1,798
1.4 claims/patient
Avg Cost/Claim
$4K
Monthly Spending Trend
Yearly Spending
2018
$2.8M
-25%
2019
$2.1M
-33%
2020
$1.4M
-8%
2021
$1.3M
-24%
2022
$964K
+30%
2023
$1.2M
-55%
2024
$567K
Procedure Breakdown
Cost per claim compared to national benchmarks
This provider bills for 1 distinct procedure code. The top code (Q5003 (Injection, infliximab-dyyb, biosimilar, 10 mg)) accounts for 100% of total spending.
ProcedureTotalYour Cost/ClaimNational Medianvs MedianPercentile
$10.3M
2,548 claims
$4,030.92
$177.99
22.6×
Top 25%
Q5003Top 25%
Injection, infliximab-dyyb, biosimilar, 10 mg
$10.3M
2,548 claims · 100.0%
Your Cost: $4,030.92/claim|Median: $177.99
22.6× median